ArticleJournal of clinical medicine2021

Osteoglycin as a Potential Biomarker of Mild Kidney Function Impairment in Type 2 Diabetes Patients.

Sheila González-Salvatierra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.